| Literature DB >> 23057635 |
Victoria K Shanmugam1, Katina Tsagaris, Amber Schilling, Sean McNish, Sameer Desale, Mihriye Mete, Michael Adams.
Abstract
BACKGROUND: The American Board of Internal Medicine Certification Examination (ABIM-CE) is one of several methods used to assess medical knowledge, an Accreditation Council for Graduate Medical Education (ACGME) core competency for graduating internal medicine residents. With recent changes in graduate medical education program directors and internal medicine residents are seeking evidence to guide decisions regarding residency elective choices. Prior studies have shown that formalized elective curricula improve subspecialty ABIM-CE scores. The primary aim of this study was to evaluate whether the number of subspecialty elective exposures or the specific subspecialties which residents complete electives in impact ABIM-CE scores.Entities:
Mesh:
Year: 2012 PMID: 23057635 PMCID: PMC3480921 DOI: 10.1186/1472-6920-12-94
Source DB: PubMed Journal: BMC Med Educ ISSN: 1472-6920 Impact factor: 2.463
Demographic variables for each annual cohort from 2006 to 2010
| n | 25 | 27 | 21 | 31 | 27 |
| Mean age, years (range) | 30 (26–35) | 31 (29–34) | 31 (28–38) | 31 (28–39) | 31 (29–35) |
| Number of men | 19 | 17 | 13 | 15 | 12 |
| Number of women | 6 | 10 | 8 | 16 | 15 |
| Male: Female ratio | 3.17 | 1.7 | 1.63 | 0.94 | 0.80 |
| Number of International Medical Graduates (IMG) | 1 | 2 | 2 | 2 | 2 |
| Number of residents passing ABIM-CE (%) | 25 (100%) | 27 (100%) | 20 (95%) | 28 (90%) | 24 (88.9%) |
| ABIM-CE mean delta-SPS (mean, range) | 162 (10–340) | 171 (29–296) | 135 (−62-339) | 113 (−13-273) | 96 (−28-277) |
| ABIM-CE standardized passing score | 351 | 351 | 370 | 370 | 370 |
| Number of residents sitting ABIM-CE ≥1 year after peer group | 2 | 3 | 0 | 2 | 0 |
| Mean number of elective exposures per resident (range) | 14 (8–18) | 15 (8–20) | 16 (12–25) | 17 (8–24) | 19 (13–25) |
Pass rate for IMG was 100% compared to 94% for US graduates (p=1.0, Fisher’s exact test).
Mean (95% CI) delta-SPS by demographic characteristics
| Female | 55 | 117.4 | 96.2-138.5 | |
| Male | 76 | 146.6 | 126.9-166.2 | |
| Age ≥31 | 67 | 133.5 | 111.8-155.3 | |
| Age ≤30 | 64 | 135.1 | 115.6-154.6 | |
| Number of elective exposures ≤14 | 44 | 143.4 | 122.5-164.3 | |
| Number of elective exposures ≥15 | 87 | 129.7 | 110.4-148.9 | |
| Number of unique electives ≤8 | 101 | 134.3 | 117.7-150.9 | |
| Number of unique electives ≥9 | 30 | 134.2 | 102.9-165.4 |
P-values calculated using two-tailed t-test. Male:Female ratio for the entire cohort was 1.38. Male:Female ratio for the group with ≤14 elective exposures was 1.32 compared to 1.41 for the group with ≥15 elective exposures (p=ns).
ABIM-CE performance by year group and elective exposure
| | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exposed | 19 | 158.9 | 21 | 172.3 | 17 | 122.5 | 31 | 112.7 | 25 | 92.6 | 113 | 128.6 | |
| (123.4 - 194.5) | | (137.4-207.3) | | (80.0-165.1) | | (82.7-142.8) | | (56.4-128.9) | | (112.7-144.5) | |||
| | Unexposed | 6 | 172.8 | 6 | 165.5 | 4 | 188.3 | 0 | - | 2 | 139.5 | 18 | 170.1 |
| (111.5-234.2) | | (90.2-240.8) | | (39.4-337.1) | | | | (69.6-209.4) | | (137.6-202.6) | |||
| | | | | | - | | | ||||||
| Exposed | 17 | 149.0 | 15 | 192.7 | 14 | 141.1 | 19 | 104.8 | 23 | 104.7 | 88 | 134.1 | |
| (108.7-189.3) | | (145.8-239.5) | | (81.8-200.5) | | (64.6-145.0) | | (67.9-141.6) | | (114.9-153.3) | |||
| | Unexposed | 8 | 190.5 | 12 | 143.5 | 7 | 122.9 | 12 | 125.3 | 4 | 46.5 | 43 | 134.8 |
| (161.8-219.2) | | (111.7-175.3) | | (83.7-162.0) | | (73.5-177.0) | | (−78.1-171.0) | | (113.7-155.8) | |||
| | | | | | | | |||||||
| Exposed | 9 | 143.7 | 16 | 168.6 | 12 | 152.2 | 22 | 109.3 | 23 | 105.6 | 82 | 129.9 | |
| (95.5-191.9) | | (130.4-206.8) | | (85.4-218.9) | | (75.3-143.4) | | (67.7-143.4) | | (111.3-148.4) | |||
| | Unexposed | 16 | 172.8 | 11 | 174.1 | 9 | 112.2 | 9 | 121.0 | 4 | 41.8 | 49 | 141.7 |
| (133.9-211.6) | | (119.3-228.9) | | (73.7-150.7) | | (45.8-196.2) | | (−33.7-117.2) | | (118.0-165.5) | |||
| | | | | | | | |||||||
| Exposed | 4 | 136.3 | 14 | 167.4 | 12 | 139.3 | 15 | 115.5 | 20 | 111.6 | 65 | 131.1 | |
| (44.9-227.6) | | (122.3-212.5) | | (93.1-185.4) | | (71.6-159.5) | | (70.7-152.4) | | (111.3-151.0) | |||
| | Unexposed | 21 | 167.2 | 13 | 174.5 | 9 | 129.4 | 16 | 110.1 | 7 | 52.0 | 66 | 137.4 |
| (134.6-199.9) | | (130.2-218.7) | | (47.4-211.5) | | (63.9-156.3) | | (−8.9-112.9) | | (115.9-158.9) | |||
| | | | | | | | |||||||
| Exposed | 24 | 162.2 | 24 | 167.0 | 16 | 135.7 | 24 | 111.5 | 23 | 94.9 | 111 | 134.5 | |
| (132.2-192.2) | | (135.5-198.5) | | (101.0-170.4) | | (76.0-147.0) | | (61.3-128.5) | | (119.6-149.5) | |||
| | Unexposed | 1 | 164.0 | 3 | 201.0 | 5 | 133.0 | 7 | 116.9 | 4 | 103.3 | 20 | 133.2 |
| | | (2.1-399.9) | | (−49.0-315.0) | | (142.4-191.3) | | (−114.7-321.2) | | (83.5-182.8) | |||
| | | - | | | | | | ||||||
| Exposed | 8 | 150.9 | 13 | 167.4 | 12 | 139.3 | 15 | 115.5 | 20 | 111.6 | 69 | 133.1 | |
| (92.0-209.7) | | (122.3-212.5) | | (93.1-185.4) | | (71.6-159.5) | | (70.7-152.4) | | (113.8-152.4) | |||
| | Unexposed | 17 | 167.6 | 14 | 174.5 | 9 | 129.4 | 16 | 110.1 | 7 | 52.0 | 62 | 135.6 |
| (131.5-204.0) | | (130.2-218.7) | | (47.4-211.5) | | (63.9-156.3) | | (−8.9-112.9) | | (113.3-157.9) | |||
| | | | | | | | |||||||
| Exposed | 17 | 161.9 | 16 | 172.4 | 14 | 169.6 | 17 | 119.2 | 13 | 62.9 | 77 | 129.9 | |
| (135.1-188.6) | | (134.4-210.5) | | (101.4-237.7) | | (76.2-162.2) | | (22.3-103.5) | | (111.5-148.3) | |||
| | Unexposed | 8 | 163.1 | 11 | 168.5 | 7 | 117.8 | 14 | 104.9 | 14 | 126.9 | 54 | 140.6 |
| (77.8-248.4) | | (113.3-223.6) | | (66.0-169.6) | | (57.4-152.3) | | (74.4-179.5) | | (116.6-164.5) | |||
| | | | | | | | |||||||
| Exposed | 19 | 164.4 | 19 | 181.5 | 15 | 158.3 | 21 | 117.1 | 19 | 99.8 | 93 | 143.0 | |
| (127.1-201.8) | | (144.4-218.5) | | (113.5-203.2) | | (53.8-145.8) | | (125.1-160.9) | | (76.5-81.1) | |||
| | Unexposed | 6 | 155.5 | 8 | 145.5 | 6 | 76.8 | 10 | 103.5 | 8 | 87.4 | 38 | 112.9 |
| (114.1-196.9) | | (90.5-200.5) | | (−3.6-157.3) | | (37.7-137.1) | | (89.4-136.5) | | (69.8-76.7) | |||
| | | | | | | | |||||||
| Exposed | 18 | 150.0 | 19 | 176.9 | 12 | 171.9 | 22 | 126.3 | 18 | 94.1 | 89 | 141.5 | |
| (120.8-179.2) | | (138.3-215.6) | | (119.3-224.6) | | (92.8-159.8) | | (52.1-136) | | (124.5-158.5) | |||
| | Unexposed | 7 | 193.9 | 8 | 156.3 | 9 | 85.9 | 9 | 79.4 | 9 | 100.2 | 42 | 119.0 |
| (111.3-276.4) | | (105.7-206.8) | | (34.3-137.5) | | (8.8-150.1) | | (29.3-171.1) | | (91.3-146.6) | |||
| | | | | | | | |||||||
| Exposed | 6 | 212.3 | 7 | 168.7 | 5 | 146.4 | 5 | 108.2 | 7 | 99.7 | 30 | 144.3 | |
| (137.2-287.5) | | (103.2-234.2) | | (18.4-274.4) | | (25.9-190.5) | | (19.8-151.9) | | (112.6-176.0) | |||
| | Unexposed | 19 | 146.5 | 20 | 171.6 | 16 | 131.5 | 26 | 113.6 | 20 | 85.9 | 101 | 131.3 |
| (116.3-176.7) | | (135.3-207.8) | | (86.6-176.4) | | (79.0-148.2) | | (57.0-142.4) | | (114.9-147.8) | |||
| 0.93 | 0.74 | 0.89 | 0.72 | 0.50 | |||||||||
Scores are reported as difference in standardized score compared to standardized passing score (delta-SPS) reported as mean (95% confidence interval). p-values represent comparison of exposed to unexposed residents for each elective exposure analyzed using unpaired two tailed t-test.
Mean delta-SPS (95% CI) by number of elective exposures in each specialty
| Cardiology | n | 18 | 39 | 74 | |
| | Mean | 170.1 | 138.6 | 123.4 | |
| | (95% CI) | (137.6-202.6) | (114.2-162.9) | (102.5-144.2) | |
| Endocrinology | n | 43 | 74 | 14 | |
| | Mean | 134.8 | 131.7 | 146.4 | |
| | (95% CI) | (113.7-155.8) | (110.5-153.0) | (96.9-195.9) | |
| Gastroenterology | n | 49 | 63 | 19 | |
| | Mean | 141.7 | 132.5 | 121.2 | |
| | (95% CI) | (118.0-165.5) | (114.0-151.0) | (65.6-176.7) | |
| Hematology | n | 66 | 63 | 2 | |
| | Mean | 137.4 | 132.7 | 81.50 | |
| | (95% CI) | (115.9-158.9) | (112.8-152.6) | (NA) | |
| Infectious Diseases | n | 20 | 64 | 47 | |
| Mean | 133.2 | 125.8 | 146.3 | | |
| | (95% CI) | (83.5-182.8) | (105.7-146.0) | (123.6-169.0) | |
| Oncology | n | 62 | 68 | 1 | |
| | Mean | 135.6 | 132.5 | 176.0 | |
| | (95% CI) | (113.3-157.9) | (113.0-152.0) | (NA) | |
| Nephrology | n | 54 | 71 | 6 | |
| | Mean | 140.6 | 136.2 | 55.33 | |
| | (95% CI) | (116.6-164.5) | (117.7-154.7) | (−33.2-143.9) | |
| Pulmonary | n | 38 | 79 | 14 | |
| | Mean | 112.9 | 145.6 | 128.7 | |
| | (95% CI) | (89.4-136.5) | (125.8-165.3) | (81.4-176.0) | |
| Rheumatology | n | 42 | 82 | 7 | |
| | Mean | 119.0 | 142.7 | 127.6 | |
| | (95% CI) | (91.3-146.6) | (124.6-160.9) | (73.7-181.4) | |
| Primary Care | n | 101 | 26 | 4 | |
| | Mean | 131.3 | 152.8 | 89.0 | |
| (95% CI) | (114.9-147.8) | (118.0-187.6) | (−0.5-178.5) |
P-value calculated using one-way ANOVA.
Mean (95% CI) subspecialty% of questions answered correctly, broken down by number of elective exposures in subspecialty of interest
| ≥ | |||||
|---|---|---|---|---|---|
| Cardiology | n | 18 | 39 | 74 | |
| | Mean (%) | 79.6 | 78.5 | 81.0 | |
| | (95% CI) | (74.9-84.2) | (75.5-81.6) | (78.8-83.3) | |
| Endocrinology | n | 43 | 74 | 14 | |
| | Mean (%) | 77.7 | 78.3 | 83.6 | |
| | (95% CI) | (74.6-80.8) | (75.5-81.1) | (80.5-86.8) | |
| Gastroenterology | n | 49 | 63 | 19 | |
| | Mean (%) | 76.9 | 78.4 | 82.1 | |
| | (95% CI) | (73.8-80.0) | (76.1-80.8) | (77.2-86.9) | |
| Hematology | n | 66 | 63 | 2 | |
| | Mean (%) | 81.4 | 80.7 | 91.5 | |
| | (95% CI) | (78.2-84.5) | (77.4-83.9) | (NA) | |
| Infectious Diseases | n | 20 | 64 | 47 | |
| Mean (%) | 80.9 | 79.3 | 81.8 | ||
| | (95% CI) | (75.7-86.2) | (76.8-81.8) | (78.8-84.7) | |
| Oncology | n | 62 | 68 | 1 | |
| | Mean (%) | 72.6 | 75.9 | 86.0 | |
| | (95% CI) | (69.4-75.7) | (72.9-78.8) | (NA) | |
| Nephrology | n | 54 | 71 | 6 | |
| | Mean (%) | 83.3 | 84.3 | 75.8 | |
| | (95% CI) | (76.9-86.7) | (81.6-86.9) | (54.9-96.8) | |
| Pulmonary | n | 38 | 79 | 14 | |
| | Mean (%) | 73.2 | 78.6 | 79.7 | |
| | (95% CI) | (69.8-76.7) | (76.1-81.1) | (73.9-85.5) | |
| Rheumatology | n | 42 | 82 | 7 | |
| | Mean (%) | 80.5 | 80.2 | 86 | |
| | (95% CI) | (77.6-83.4) | (77.8-82.6) | (80.3-91.7) | |
| Primary Care | n | 101 | 26 | 4 | |
| | Mean (%) | 75.3 | 78.0 | 74.5 | |
| (95% CI) | (73.7-76.9) | (74.3-81.6) | (56.8-92.2) |
p-values calculated using 1-way ANOVA.
Mean (95% CI)% correct in respective subspecialties for each elective exposure
| Cardiology | n | 18 | 113 | |
| | Mean | 79.6 | 80.2 | |
| | (95% CI) | (74.9-84.2) | (78.3-81.9) | |
| Endocrinology | n | 43 | 88 | |
| | Mean | 77.7 | 79.2 | |
| | (95% CI) | (74.6-80.8) | (76.7-81.6) | |
| Gastroenterology | n | 49 | 82 | |
| | Mean | 76.9 | 79.3 | |
| | (95% CI) | (73.9-80.0) | (77.2-81.4) | |
| Hematology | n | 66 | 65 | |
| | Mean | 81.4 | 81.0 | |
| | (95% CI) | (78.2-84.5) | (77.8-84.2) | |
| Infectious Diseases | n | 20 | 111 | |
| Mean | 80.9 | 80.4 | ||
| | (95% CI) | (75.7-86.2) | (78.5-82.3) | |
| Oncology | n | 62 | 69 | |
| | Mean | 72.6 | 76.0 | |
| | (95% CI) | (69.4-75.7) | (73.1-78.9) | |
| Nephrology | n | 54 | 74 | |
| | Mean | 83.3 | 83.6 | |
| | (95% CI) | (79.9-86.7) | (80.9-86.4) | |
| Pulmonary | n | 38 | 93 | |
| | Mean | 73.2 | 78.8 | |
| | (95% CI) | (69.8-76.7) | (76.5-81.1) | |
| Rheumatology | n | 42 | 89 | |
| | Mean | 80.48 | 80.64 | |
| | (95% CI) | (77.6-83.4) | (78.4-82.9) | |
| Primary Care | n | 101 | 30 | |
| | Mean | 75.3 | 77.5 | |
| (95% CI) | (73.6-76.9) | (74.1-80.9) |
P-value calculated using two-tailed unpaired t-testP-value calculated using two-tailed unpaired t-test.